New technologies and techniques for prostate cancer focal therapy: a review of the current literature.

CONCLUSIONS: Reliable evidence for the partial-gland treatment of PCa is increasing, and encouraging mid-term oncologic outcomes with the preservation of sexual and urinary functions have been reported. Accurate patient selection at the outset of treatment and careful follow-up seem key attributes to achieve excellent functional results and encouraging oncological outcomes. PMID: 29664243 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29664243?dopt=Abstract

Source: Minerva Urologica e Nefrologica - April 19, 2018 Category: Urology & Nephrology Tags: Minerva Urol Nefrol Source Type: research